APAC Weight Loss and Diet Management Market Research Report – Segmented By Diet, Equipment, Services and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends and Growth Forecast (2024 to 2029)

Updated On: January, 2024
ID: 1660
Pages: 140

APAC Weight Loss and Diet Management Market Size (2023 to 2028)

The size of the Weight Loss & Diet Management Market in the Asia Pacific is projected to reach USD 109.58 billion by 2028 from USD 62.77 billion in 2023, growing at a CAGR of 11.79% during the forecast period.

The Asia Pacific weight loss & diet management market is expected to grow during the forecast period owing to driving factors such as increased levels of obesity awareness and weight gain, high rate of entry of new products to the market for weight gain, technological advancements in fitness equipment, government initiatives and education on the health risks of overweight and a lifestyle hectic. As a result, the increasing number of bariatric surgeries drives the market's growth. Bariatric surgeries/weight loss surgeries were previously considered the last weight loss option after diet, exercise, and other doctor-prescribed programs failed. However, with the advancement of technology, bariatric surgeries have become less painful for patients. For this reason, these surgeries are increasingly accepted by the medical community as an effective and sustainable alternative to other weight loss techniques. Furthermore, with a rapid increase in obesity rates, this factor has led to rapid growth in bariatric surgeries across APAC.

However, the product and services' high cost and the associated security issues are expected to restrain the market's growth during the forecast period. In addition, safety concerns associated with the equipment and lack of consumer awareness in remote and suburban areas are expected to affect weight loss and the development of diet management products.

This research report on the Asia Pacific Weight Loss and Diet Management Market has been segmented and sub-segmented into the following categories:

By Diet:

  • Food & Beverages
  • Diet Supplements

By Equipment:

  • Fitness Training Equipment
  • Surgical Equipment
    • Minimally Invasive/Bariatric Surgical Equipment
    • Non-Invasive Surgical Equipment

By Services:

  • Fitness Centers
  • Consulting Services

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regional Analysis:

The APAC region is expected to grow rapidly during the forecast period compared to other regional markets due to its growing obese and diabetic population, sedentary lifestyle, and increasing disposable income. China dominates the weight-loss monitoring market in the Asia-Pacific region due to the increasing prevalence of overweight and obesity. Other factors driving the market's growth include increased awareness of personal well-being and increased disposable income. Consumers in the region primarily prefer weight-loss teas and meal replacements, among other products. These include all herbal and non-herbal slimming teas and low-calorie meal replacements such as shakes, powders, soups, and bars. Despite the backlash against weight loss supplements, the meal replacement category has grown. These products are seen as healthier alternatives to over-the-counter obesity and weight loss supplements. These meal replacements are healthier and safer because they provide less calorie density. Yet, at the same time, they provide essential nutrients, vitamins, and minerals necessary for healthy eating and weight loss.

Companies playing a promising role in the Asia Pacific weight loss and diet management market profiled in the report are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health, Inc., Merck & Co. Inc. and Protein Sciences.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample